Ftse Mib
36.284,91
1,30%
DAX
20.917,57
1,38%
S&P 500
5.992,01
0,92%
NASDAQ
19.604,52
1,38%
Bitcoin
104.172,86
4,16%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC UCB NPV (PK) (UCBJF) UCB NPV (PK) (UCBJF) Notizie

UCBJF

UCB NPV (PK) (UCBJF)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:UCBJF
DataOraFonteTitoloSimboloCompagnia
28/03/202214:01TipRanksUCB’s Childhood Epilepsy Drug Gets FDA NodUSOTC:UCBJFUCB NPV (PK)
27/03/201416:00ZacksBristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
22/05/201323:55ZacksData on UCB's Neupro - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
15/05/201313:26ZacksNektar Posts Wider Loss, Maintains View - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
03/05/201316:16ZacksQuestcor Misses on Earnings, Revs - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
03/05/201315:05ZacksValeant Beats Earnings, Misses Revs - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
03/05/201314:54ZacksShire Beats Earnings in 1Q - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
02/05/201319:00ZacksGlaxo's Trametinib Delayed - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
02/05/201315:09ZacksViroPharma Reports Loss in 1Q - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
02/05/201311:50ZacksActavis Beats on Earnings, Raises View - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
02/05/201311:19ZacksLoss Widens at Momenta - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
02/05/201310:06ZacksEarnings and Sales Rise at Novo Nordisk - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
01/05/201318:18ZacksNovo Nordisk and EMIS Modify Deal - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
01/05/201314:55ZacksShire Settles Lawsuit with Actavis - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
01/05/201314:03ZacksAllergan Beats on Earnings - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
01/05/201312:31ZacksPositive CHMP Opinion for Avanir - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
01/05/201310:29ZacksMerck Earnings Decline Y/Y, Cuts Outlook - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
30/04/201318:30ZacksCHMP Backs VIVUS' Spedra - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
30/04/201318:15ZacksGlaxo-Impax End Rytary Deal - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
30/04/201314:46ZacksWider Loss at Auxilium, Acquires Actient - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
30/04/201312:54ZacksPfizer Misses on Earnings, Revs, Cuts Outlook - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
29/04/201319:30ZacksPositive News for Roche - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
29/04/201318:40ZacksCHMP in Favor of Celgene's Revlimid - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
29/04/201311:40ZacksEarnings Miss at UTHR - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
26/04/201318:00ZacksBayer Earnings Rise Y/Y - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
26/04/201314:03ZacksAstraZeneca Earnings Tumble Y/Y - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
26/04/201313:42ZacksEarnings Beat for AbbVie - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
25/04/201319:30ZacksAcorda Initiates Study on rHIgM22 - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
25/04/201314:18ZacksLoss Widens at XenoPort - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
25/04/201313:41ZacksEarnings Beat at Alexion, Ups View - Analyst BlogUSOTC:UCBJFUCB NPV (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:UCBJF

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
LDO
Leonardo
BIT
SRG
Snam
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
CPR
Davide Campari
BIT
SPM
Saipem
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
MONC
Moncler
BIT
IVG
Iveco Group NV
BIT
AMP
Amplifon
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network